Genentech extends small-molecule R&D with three platform deals
Pfizer selects first GPCR candidate from Sosei Heptares tie-up
Shinichi Tamura re-takes CEO role at Sosei
Sosei shares tank after safety issue with Alzheimer’s drug
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
Sosei see Teva pipeline cull as an opportunity